Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 67%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

CareTrust REIT is a self-administered, publicly traded REIT that is well-positioned to deploy capital aggressively through its investments in healthcare-related real estate assets in Domestic and Foreign markets, as it operates in three property segments including US SNFs, UK care homes, and US SHOP. Although there is high competition in the SHOP segment and private market valuations are trending higher, the significant outperformance in SHOP exposed public REITs and the supply gap in this asset class for baby boomers provide a strong investment outlook for CareTrust REIT. However, there are potential risks such as the unpredictable regulatory environment and potential issues with new tenants that may emerge, which could impact profitability and dilute earnings. It is critical for CareTrust REIT to properly underwrite its acquisitions and leases with operators in the ever-evolving healthcare environment to meet return hurdles. There is also potential risk in tenant concentration, as Ensign comprises a significant percentage of CTRE's NOI, and the availability of investment opportunities and market conditions may also impact profitability.

Bears say

CareTrust REIT is facing negative pressure as a result of uncertainties in the regulatory environment, potential credit issues with tenants, and a competitive investment market. Though recent signs of stability in the fundamental environment and management's portfolio optimization plan may provide some relief, the company's primarily triple-net lease structure and heavy reliance on third-party operators leave it exposed to potential risks and earnings volatility. There is also the potential for further dilution from increased debt and preferred equity investments in the coming years.

CareTrust REIT (CTRE) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 67% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 9 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.